Therapeutic effects of rectal Diclofenac sodium and intramuscular pethedine injection in the treatment of acute renal colic: A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201408129936N9

Enrollment

600

Registered

2014-09-22

Start date

2010-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic (duo to renal stone). Unspecified renal colic

Interventions

Intervention 1: Suppository Diclofenac 100mg stat dose. Intervention 2: Pethedin IM 50mg stat dose.

Treatment - Drugs

Suppository Diclofenac 100mg stat dose

Pethedin IM 50mg stat dose

Eligibility

Sex/Gender

All

Age

17 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria; all patients with renal colic pain (with impression of renal stone); age between 17 to 55 years old. Exclusion criteria: allergy to NSAIDs; hemorrhoid; anal fissure; acid peptic disease; coagulopathy; pregnancy; heart disease; COPD; liver failure; renal failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The pain score in each group. Timepoint: 10, 20, 30 and 60 minutes after using the drug ( intervention). Method of measurement: Numeric pain intensity scale (VAS Scoring system).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Ghahramani, MD

Colorectal Research Center, Shiraz university of medical sciences

leila_ghahramani@yahoo.com+98 71 1230 6972

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026